GT201000062A - Composiciones farmacéuticas liofilizadas - Google Patents
Composiciones farmacéuticas liofilizadasInfo
- Publication number
- GT201000062A GT201000062A GT201000062A GT201000062A GT201000062A GT 201000062 A GT201000062 A GT 201000062A GT 201000062 A GT201000062 A GT 201000062A GT 201000062 A GT201000062 A GT 201000062A GT 201000062 A GT201000062 A GT 201000062A
- Authority
- GT
- Guatemala
- Prior art keywords
- liofilized
- pharmaceutical compositions
- liofilization
- freezing
- extracts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES FARMACÉUTICAS LIOFILIZADAS QUE COMPRENDEN COMPUESTOS DE HIDROXAMATO APROVECHANDO LAS CARACTERÍSTICAS DEL PROCESO DE LIOFILIZACIÓN COMO LO ES EL SECADO POR CONGELACIÓN EL CUAL EXTRAE EL AGUA DE UNA SOLUCIÓN PARA FORMAR UN SÓLIDO GRANULAR O POLVO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97383007P | 2007-09-20 | 2007-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201000062A true GT201000062A (es) | 2012-03-30 |
Family
ID=40005335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201000062A GT201000062A (es) | 2007-09-20 | 2010-03-16 | Composiciones farmacéuticas liofilizadas |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100331387A1 (es) |
EP (1) | EP2205222A1 (es) |
JP (1) | JP2010540445A (es) |
KR (1) | KR20100059887A (es) |
CN (1) | CN101801345A (es) |
AR (1) | AR068822A1 (es) |
AU (1) | AU2008302273A1 (es) |
BR (1) | BRPI0817118A2 (es) |
CA (1) | CA2696914A1 (es) |
CL (1) | CL2008002786A1 (es) |
CO (1) | CO6270207A2 (es) |
EC (1) | ECSP10010039A (es) |
GT (1) | GT201000062A (es) |
MA (1) | MA31744B1 (es) |
MX (1) | MX2010002970A (es) |
PE (1) | PE20090706A1 (es) |
RU (1) | RU2010115262A (es) |
TN (1) | TN2010000097A1 (es) |
TW (1) | TW200930416A (es) |
WO (1) | WO2009039226A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018011760A (es) * | 2016-03-31 | 2019-02-20 | Midatech Ltd | Aducto de ciclodextrina-panobinostat. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
US7250514B1 (en) * | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
DE602004010407T2 (de) * | 2003-07-23 | 2008-10-16 | Bayer Pharmaceuticals Corp., West Haven | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden |
JP2007501775A (ja) * | 2003-08-07 | 2007-02-01 | ノバルティス アクチエンゲゼルシャフト | 免疫抑制剤としてのヒストンデアセチラーゼ阻害剤 |
PE20060664A1 (es) * | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
US20060128660A1 (en) * | 2004-12-10 | 2006-06-15 | Wisconsin Alumni Research Foundation | FK228 analogs and methods of making and using the same |
US7604939B2 (en) * | 2005-03-01 | 2009-10-20 | The Regents Of The University Of Michigan | Methods of identifying active BRM expression-promoting HDAC inhibitors |
WO2008086330A2 (en) * | 2007-01-10 | 2008-07-17 | Novartis Ag | Formulations of deacetylase inhibitors |
AU2008216327A1 (en) * | 2007-02-15 | 2008-08-21 | Novartis Ag | Combination of LBH589 with other therapeutic agents for treating cancer |
-
2008
- 2008-09-17 CL CL2008002786A patent/CL2008002786A1/es unknown
- 2008-09-18 AU AU2008302273A patent/AU2008302273A1/en not_active Abandoned
- 2008-09-18 RU RU2010115262/15A patent/RU2010115262A/ru unknown
- 2008-09-18 CA CA2696914A patent/CA2696914A1/en not_active Abandoned
- 2008-09-18 EP EP08832517A patent/EP2205222A1/en not_active Withdrawn
- 2008-09-18 AR ARP080104055A patent/AR068822A1/es unknown
- 2008-09-18 KR KR1020107006075A patent/KR20100059887A/ko not_active Application Discontinuation
- 2008-09-18 BR BRPI0817118A patent/BRPI0817118A2/pt not_active IP Right Cessation
- 2008-09-18 CN CN200880107798A patent/CN101801345A/zh active Pending
- 2008-09-18 US US12/676,755 patent/US20100331387A1/en not_active Abandoned
- 2008-09-18 JP JP2010525936A patent/JP2010540445A/ja active Pending
- 2008-09-18 MX MX2010002970A patent/MX2010002970A/es not_active Application Discontinuation
- 2008-09-18 PE PE2008001634A patent/PE20090706A1/es not_active Application Discontinuation
- 2008-09-18 WO PCT/US2008/076752 patent/WO2009039226A1/en active Application Filing
- 2008-09-19 TW TW097136190A patent/TW200930416A/zh unknown
-
2010
- 2010-02-25 TN TNP2010000097A patent/TN2010000097A1/fr unknown
- 2010-03-12 MA MA32691A patent/MA31744B1/fr unknown
- 2010-03-16 GT GT201000062A patent/GT201000062A/es unknown
- 2010-03-17 EC EC2010010039A patent/ECSP10010039A/es unknown
- 2010-03-25 CO CO10035474A patent/CO6270207A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101801345A (zh) | 2010-08-11 |
CL2008002786A1 (es) | 2009-05-15 |
AR068822A1 (es) | 2009-12-09 |
ECSP10010039A (es) | 2010-04-30 |
RU2010115262A (ru) | 2011-10-27 |
CO6270207A2 (es) | 2011-04-20 |
CA2696914A1 (en) | 2009-03-26 |
EP2205222A1 (en) | 2010-07-14 |
US20100331387A1 (en) | 2010-12-30 |
WO2009039226A1 (en) | 2009-03-26 |
TN2010000097A1 (en) | 2011-09-26 |
JP2010540445A (ja) | 2010-12-24 |
MA31744B1 (fr) | 2010-10-01 |
AU2008302273A1 (en) | 2009-03-26 |
TW200930416A (en) | 2009-07-16 |
PE20090706A1 (es) | 2009-07-15 |
MX2010002970A (es) | 2010-04-01 |
KR20100059887A (ko) | 2010-06-04 |
BRPI0817118A2 (pt) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
HN2011001256A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratmiento o prevencion de diabetes | |
GT201000376A (es) | Compuestos organicos | |
SMT201600055B (it) | Composizione farmaceutica per il trattamento o la prevenzione del glaucoma | |
GT201200230A (es) | Inhibidores del virus de la hepatitis c | |
GT201400102A (es) | 4-fenil-piridinas sustituidas para el tratamiento de enfermedades relacionadas con el receptor de nk1 | |
CR20140036A (es) | Compuesto inhibidor de la señalización de la trayectoria notch | |
CL2014001065A1 (es) | Compuestos derivados de piridopirazinas; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de un estado patologico o afeccion mediada por una fgfr cinasa tal como cancer. | |
CR20110046A (es) | Amidofenoxiindazoles utiles como inhibidores de c-met | |
CL2015000213A1 (es) | Composiciones detergentes líquidas concentradas que comprende al menos el 0,25% en peso de polimero de liberacion de la suciedad. | |
CU20110052A7 (es) | Compuestos orgánicos | |
NI201200017A (es) | Formulación farmacéutica | |
NI200900148A (es) | COMPUESTOS TRICÍCLICOS, COMPOSICIONES, Y PROCEDIMIENTOS. Caso: PC33536A | |
GT200900329A (es) | Desodorante basado en propilenglicol/glicerina | |
CR20140229A (es) | Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona | |
UY33241A (es) | ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?. | |
UY33246A (es) | Tienopirimidinas que contienen cicloalquilo para composiciones farmacéuticas | |
GT201300009A (es) | Derivados de tetrahidro-pirido-pirimidina | |
UY30220A1 (es) | Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo | |
CR20110255A (es) | Nuevos compuestos 578 | |
UY31925A (es) | Isoquinolinas e isoquinolinonas sustituidas | |
NZ749649A (en) | Peroxycarboxylic acid compositions containing fluorescent active compounds for inline optical monitoring | |
HN2010002558A (es) | DERIVADOS DE UREA MACROCICLICOS Y DE SULFAMIDA COMO INHIBIDORES DE TAFIa | |
ECSP14026088A (es) | Compuestos de pirazol como inhibidores de sglt1 | |
CR20150325A (es) | Compuestos trcíclicos para inhibir el canal cftr |